Freshpet Form 3: Interim CFO discloses share and option holdings

Rhea-AI Filing Summary

Freshpet (FRPT) filed a Form 3 disclosing the interim CFO’s beneficial ownership as of 10/17/2025. The officer reports 6,527 shares of common stock, consisting of 4,855 shares and 1,672 unvested RSUs. RSUs are scheduled to vest as follows: 355 on March 13, 2026; 392 in two equal installments beginning March 15, 2026; and 925 in three equal annual installments beginning March 11, 2026, subject to continued service. The filing also lists options for 27,000 shares at $49.77, fully vested, expiring on 10/01/2029.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Garcia Ivan

(Last) (First) (Middle)

C/O FRESHPET, INC.

1450 US-206

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/17/2025

3. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common stock	6,527(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock	(2)	10/01/2029	Common Stock	27,000	$49.77	D

Explanation of Responses:

1. Consists of (i) 4,855 shares of common stock and (ii) 1,672 unvested restricted stock units (RSUs) awarded to the Reporting Person in various awards under the Issuer's 2014 Omnibus Incentive Plan and 2024 Omnibus Incentive Plan, of which (a) 355 RSUs will vest on March 13, 2026, (b) 392 RSUs will vest in two remaining equal installments beginning March 15, 2026, and (c) 925 RSUs will vest in three equal annual installments beginning March 11, 2026, subject in each case to the Reporting Person's continued service with the Company.

2. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan and are fully vested.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Andrew Lampert as attorney-in-fact for the Reporting Person	10/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FRPT disclose in this Form 3?

An interim CFO’s holdings: 6,527 common shares (including 1,672 unvested RSUs) and options for 27,000 shares at $49.77.

What is the officer’s role noted in the filing for FRPT?

The reporting person is an Officer, serving as Interim CFO.

When is the event date for the reported holdings of FRPT?

The event date is 10/17/2025.

What are the FRPT RSU vesting schedules in this filing?

355 on March 13, 2026; 392 in two equal installments beginning March 15, 2026; 925 in three equal annual installments beginning March 11, 2026.

What derivative securities did FRPT’s officer report?

Options to purchase 27,000 shares at $49.77, fully vested, expiring on 10/01/2029.

How many FRPT shares are directly owned vs. unvested RSUs?

4,855 shares directly owned and 1,672 unvested RSUs.